Literature DB >> 25987013

Emerging roles of Krüppel-like factor 4 in cancer and cancer stem cells.

Bo Ding1, Ping Liu, Wen Liu, Ping Sun, Chun-Ling Wang.   

Abstract

Cancer stem cells (CSCs) are rare subpopulations within tumors which are recognized as culprits in cancer recurrence, drug resistance and metastasis. However, the molecular mechanisms of how CSCs are regulated remain elusive. Kruppel-like factors (KLFs) are evolutionarily conserved zinc finger-containing transcription factors with diverse functions in cell differentiation, proliferation, embryogenesis and pluripotency. Recent progress has highlighted the significance of KLFs, especially KLF4, in cancer and CSCs. Therefore, for better therapeutics of cancer disease, it is crucial to develop a deeper understanding of the mechanisms of how KLF4 regulate CSC functions. Herein we summarized the current understanding of the transcriptional regulation of KLF4 in CSCs, and discussed the functional implications of targeting CSCs for potential cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25987013     DOI: 10.7314/apjcp.2015.16.9.3629

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  Role of Krüppel-like factor 4 and heat shock protein 27 in cancer of the larynx.

Authors:  Jihad Karam; Marie Claude Fadous-Khalifé; Rita Tannous; Sally Fakhreddine; Marcel Massoud; Joseph Hadchity; Georges Aftimos; Elie Hadchity
Journal:  Mol Clin Oncol       Date:  2017-09-19

2.  Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins.

Authors:  Jiajie George Lu; Luan Nguyen; Sara Samadzadeh; Maryam Masouminia; Alejandro Mendoza; Owen Sweeney; Brittany Tillman; Nikoo Afifyan; Timothy Morgan; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2018-02-06       Impact factor: 3.362

3.  Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.

Authors:  H Sun; Z Peng; H Tang; D Xie; Z Jia; L Zhong; S Zhao; Z Ma; Y Gao; L Zeng; R Luo; K Xie
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

4.  KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling.

Authors:  Yandong Li; Shijun Yu; Li Li; Jingde Chen; Ming Quan; Qinchuan Li; Yong Gao
Journal:  Cell Death Dis       Date:  2020-04-29       Impact factor: 8.469

5.  Krüppel-like factor 4 promotes high-mobility group box 1-induced chemotherapy resistance in osteosarcoma cells.

Authors:  Jun Huang; Ke Liu; Deye Song; Muliang Ding; Junjie Wang; Qingping Jin; Jiangdong Ni
Journal:  Cancer Sci       Date:  2016-02-18       Impact factor: 6.716

Review 6.  Cancer stem cells (CSCs), cervical CSCs and targeted therapies.

Authors:  Ruixia Huang; Einar K Rofstad
Journal:  Oncotarget       Date:  2017-05-23

Review 7.  The Role of KLF4 in Alzheimer's Disease.

Authors:  Ziqian Cheng; Xiaohan Zou; Yang Jin; Shuohui Gao; Jiayin Lv; Bingjin Li; Ranji Cui
Journal:  Front Cell Neurosci       Date:  2018-09-21       Impact factor: 5.505

Review 8.  The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway.

Authors:  Laura Martin-Hijano; Bruno Sainz
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

9.  Long non-coding RNA LINC00673 silencing inhibits proliferation and drug resistance of prostate cancer cells via decreasing KLF4 promoter methylation.

Authors:  Zhenming Jiang; Yuxi Zhang; Xi Chen; Pingeng Wu; Dong Chen
Journal:  J Cell Mol Med       Date:  2019-12-27       Impact factor: 5.310

Review 10.  Differences and similarities between cancer and somatic stem cells: therapeutic implications.

Authors:  Fiorella Rossi; Hunter Noren; Richard Jove; Vladimir Beljanski; Karl-Henrik Grinnemo
Journal:  Stem Cell Res Ther       Date:  2020-11-18       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.